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Abstract Catecholamine regulates the Na+,K+-ATPase activity 
in the central nervous system and the Na+,K+-ATPase has been 
shown to have endogenous ligands (ouabain-like compound; 
OLC). To examine the relationship between OLC and central 
adrenergic neurons, we evaluated the effects of central sympath- 
ectomies with intracerebroventricular (i.c.v.) injection of 6-hy- 
droxydopamine (6-OHDA; 250/xg) on brain and plasma OLC 
levels and brain catecholamine l vels. In centrally sympathecto- 
mized rats, hypothalamic OLC content and plasma OLC level 
were significantly decreased by 90% (P< 0.01) and 70% 
(P < 0.01), respectively, in accordance with reduced brain nor- 
epinephrine content compared with control rats pretreated by 
i.c.v, injection of vehicle (ascorbic acid). On the other hand, 
peripheral sympathectomy with a similar manner did not affect 
plasma OLC level at all. These findings suggest that central 
adrenergic neurons may be involved in the synthesis and/or re- 
lease of circulating OLC. 
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1. Introduction 
It is believed that central adrenergic neurons are involved in 
the initiation and development of experimental hypertension. 
The destruction of central adrenergic neurons by intracere- 
broventricular (i.c.v.) infusion of 6-hydroxydopamine (6- 
OHDA)  interferes with the development of nearly all types of 
experimental hypertension [1 3]. Na+,K+-ATPase has a major 
role in the regulation of neural excitability and energy metabo- 
lism and it has recently been shown that there are three 
isoforms of the catalytic (~) subunit of Na+,K+-ATPase that 
differ in their sensitivity to inhibition by cardiac glycosides [4]. 
In the rat, c¢1 has low affinity for ouabain, whereas ~2 and ~3 
have high affinities for ouabain [5]. As 0~2 and ~3 isoforms are 
predominant in the rat brain and the ouabain binding site of 
Na+,K+-ATPase has been shown to have endogenous ligands 
(ouabain-like compound; OLC) [6,7], the role of brain OLC in 
cardiovascular regulation have attracted much interest [8,9]. 
Huang and coworkers provided evidence that brain OLC 
may participate in the sympathoexcitatory and pressor effects 
of i.c.v, infusion of hypertonic saline solution [8]. We have 
recently shown that brain OLC may be involved in central 
nervous system (CNS)-mediated natriuresis in rats [10]. We 
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undertook the present study to examine the interaction between 
brain OLC and central adrenergic neurons. For this, we evalu- 
ated the effects of central and peripheral sympathectomy on 
tissue and plasma OLC levels in rats. 
2. Materials and methods 
2.1. Central sympathectomy 
Male Wistar rats were centrally sympathectomized by i.c.v, injections 
of 6-OHDA. Male Wistar rats weighing 300 to 330 g (n = 11) were 
anesthetized with pentobarbital nd were placed in a Kopf stereotaxic 
apparatus. A burr hole was made approximately 0.5 mm posterior to 
the bregma and 1.5 mm lateral to the midsagittal suture. A stainless 
steel cannula was introduced stereotaxically into the left lateral ventri- 
cle (4.5 mm below the skull surface). 6-OHDA (250/.tg) in 20/11 phys- 
iological saline solution containing 0.1% ascorbic acid was injected into 
the left lateral ventricle via a 25/~1 Hamilton syringe. Control rats 
(n = 9) received 20/A physiological saline solution containing 0,1% 
ascorbic acid. Twenty four hours after the injection the animals were 
killed by decapitation. Trunk blood was collected into a tube containing 
EDTA-2Na. Plasma OLC was measured by radioimmunoassay for
ouabain. The brain was removed and was dissected into the following 
regions: right and left hypothalamus and left cortex [11]. Right and left 
hypothalamus were used for the measurements of Na*,K+-ATPase ac- 
tivity and OLC content, respectively. Norepinephrine content of left 
cortex was measured to determine the validity of sympathectomy. 
2.2. Peripheral sympathectomy 
Peripheral sympathectomy was performed by a single intravenous 
injection of 6-OHDA. 6-OHDA (66 mg) in 0.8 ml of physiological 
saline solution containing 0.1% ascorbic acid was injected into the tail 
vein of 8 male Wistar rats weighing 300 g under conscious and re- 
strained condition. Control rats (n -- 10) received 0.8 ml of physiologi- 
cal saline solution containing 0.1% ascorbic acid. Twenty-four hours 
later rats were killed by decapitation to determine plasma OLC level 
and the content of OLC in heart, kidney and adrenals. 
2.3. Measurement ofOLC 
The tissue samples were homogenized with 5 vols. of distilled water 
and the homogenates were centrifuged at 15,000 rpm for 60 min. The 
resulting supernatant and the plasma sample (1.0 ml) mixed with the 
equal volume of 0.1% TFA solution were applied to Sep-Pak C~8 car- 
tridge that had been activated with methanol and equilibrated with 
distilled water. After complete washing with 30 ml of distilled water, 
OLC was eluted with 3 ml of 25% acetonitrile in water. The eluent was 
evaporated and assayed for OLC based on radioimmunoassay for 
ouabain as described in our previous report [12]. 
2.4. Measurement ofNa+,K+-ATPase activity 
Preparation of microsomes from cerebral cortex and assay of 
Na+,K+-ATPase activity were performed according to the method e- 
scribed by Donaldson et al. [13]. Briefly, a heavy microsomal fraction 
was prepared from cerebral cortex and was preincubated with 50 mM 
Tris-HC1 buffer containing 2 mM MgC12, 100 mM NaC1, and 20 mM 
KC1 (pH 7.6). Tris-ATP was added to the mixture (final concentration: 
2.5 mM) and the reaction was terminated after 10 min by the addition 
of trichloroacetic a id. Inorganic phosphate (Pi) released was measured 
by the ascorbic acid method [14] and was expressed as mg Pi released 
in 10 min per ~tg of protein. 
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2.5. Statistics 
The data are expressed asmean + S,E.M. and were analyzed by the 
unpaired Student's t-test. 
3. Results 
A summary of the effect of central sympathectomy on meas- 
ured parameters is shown in Table 1. The norepinephrine and 
epinephrine levels in the cerebral cortex were significantly lower 
in centrally sympathectomized rats compared to those in con- 
trol rats. The dopamine levels were not significantly different 
between the two groups of rats. The hypothalamic OLC con- 
tent in centrally sympathectomized rats was 0.8 + 0.2 pmol/g 
and was markedly lower than that in control rats (8.0 + 1.8, 
P < 0.01; Fig. 1). The plasma OLC level was also significantly 
lower in centrally sympathectomized rats compared to that in 
control rats (74 _+ 19 vs. 243 + 47 pmol/1, P < 0.01; Fig. 2). 
Na+,K+-ATPase activity of the hypothalamus was higher in 
centrally sympathectomized rats compared to that in control 
rats, but the difference was not significant (6.2 + 1.1 vs. 
3.6 + 1.6 mg P~/10 min/mg protein; NS). As shown in Table 2, 
intravenous injection of 6-OHDA did not influence the OLC 
levels of plasma nd three organs examined. 
4. Discuss ion 
Injection of 6-OHDA into a brain ventricle or the cisterna 
magna causes degeneration f central adrenergic nerve termi- 
nals without affecting peripheral adrenergic nerves [15]. I.c.v. 
injection of 6-OHDA has been shown to prevent development 
of hypertension i  one-kidney one-clip hypertensive and one- 
kidney DOCA-salt hypertensive and young spontaneously h - 
pertensive rats [1,2]. Further, Huot et al. have reported that 
i.c.v, injection of 6-OHDA markedly attenuated the develop- 
ment of reduced renal mass hypertension, prevented inhibition 
of vascular Na+,K+-ATPase pump activity in these animals, 
and prevented appearance of a circulating sodium transport 
inhibitor in their plasma [3]. 
OLC exhibiting Na+,K+-ATPase inhibitory activity has been 
extracted and partially purified from mammalian brain, hypo- 
thalamus and cerebrospinal fluid [6,7,16]. Recently, Tymiak et 
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Fig. 1. Hypothalamic ouabain-like compound (OLC) content in control 
rats (n = 9) and centrally sympathectomized ratsby intracerebroven- 
tricular injection of 6-hydroxydopamine (6-OHDA; n = 11). 
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Fig. 2. Plasma ouabain-like compound (OLC) level in control rats 
(n = 9) and centrally sympathectomized rats by intracerebroventricular 
injection of 6-hydroxydopamine (6-OHDA; n = 11). 
[17]. Furthermore, the presence of OLC has been demonstrated 
by immunohistochemical methods in hypothalamus of rat and 
macaque [I 8]. We have previously shown that i.c.v, preinjection 
of the Fab fragment of digoxin-specific antibody (Digibind) 
significantly inhibited increases in renal sodium excretion in 
response to high central sodium and suggested that brain OLC 
may be involved in CNS-mediated natriuresis [10]. 
In the present study, noradrenaline measurement i dicates 
that central sympathectomies were effective. Central sympath- 
ectomy by i.c.v, injection of 6-OHDA markedly reduced not 
only the OLC content in hypothalamus but also plasma OLC 
level. On the other hand, peripheral sympathectomy did not 
affect plasma OLC level. These findings suggest hat central 
adrenergic neurons may be involved in the synthesis and/or 
release of OLC in rats. Furthermore, it appears that circulating 
OLC derives from the central nervous ystem. 
We could not find significant change in the Na +, K+-ATPase 
activity in hypothalamus. Swann et al. have shown that acute 
noradrenergic stimulation i  vivo increased and 6-OHDA le- 
sions decreased Na+,K+-ATPase activity in brain [19] and that 
Table 1 
Effects of central sympathectomy on measured parameters 
Control 6-OHDA p 
(n=9) (n= 11) 
Norepinephrine content in cerebral 
cortex (ng/g) 102 + 15 <0.05 
Epinephrine content in cerebral 
cortex (ng/g) 83 + 15 <0.05 
Dopamine content in cerebral 
cortex (ng/g) 621 + 101 NS 
OLC content in hypothalamus 
(pmol/g) 0.8 + 0.2 <0.01 
Plasma OLC level (pmol/l) 74 + 19 < 0.01 
Na+,K+-ATPase activity in hypo- 
thalamus (ttg Pi/10 min/mg protein) 3.6 + 1.6 6.2 + 1.1 NS 
368 + 84 
474 + 204 
855 + 125 
8.0 + 1.8 
243 + 47 
Values are given as means + S.E.M. OLC = ouabain-like compound; 
6-OHDA = 6-hydroxydopamine. 
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Table 2 
Plasma and tissue OLC levels in control and intravenously 6-OHDA 
infused rats 
Control 6-OHDA p 
(n = 10) (n = 8) 
Plasma (pmol/1) 60 + 5 65 + 23 NS 
Adrenals (pmol/g) 2.77 + 0.17 2.98 + 0.47 NS 
Kidney (pmol/g) 0.21 + 0.03 0.22 + 0.09 NS 
Heart (pmol/g) 0.72 +_ 0.30 0.14 + 0.03 NS 
Values are given as means + S.E.M. OLC = ouabain-like compound; 
6-OHDA = 6-hydroxydopamine. 
repeated noradrenergic stimulation for 3 weeks increased 
ouabain binding to rat cortex membrane [18]. In the rat brain, 
two isoforms (c~2 and ~3) with high affinity to ouabain exist [5]. 
In this context, it is supposed that the decrease of OLC in 
hypothalamus may increase the Na+,K+-ATPase activity in hy- 
pothalamus. OLC content and Na+,K+-ATPase activity were 
measured using different parts of hypothalamus in this study. 
Significant change might be detected if we could measure these 
two parameters using the same material. In order to evaluate 
the exact relationship between OLC and Na+,K+-ATPase activ- 
ity, we surely need to measure the each isoform specific 
Na+,K+-ATPase activity. 
In conclusion, our observation i dicates that central sympa- 
thectomy acutely decreased OLC in hypothalamus and plasma, 
but that peripheral sympathectomy did not influence plasma 
OLC level. These results support he view the brain OLC may 
be modulated by adrenergic neurons and may be the source of 
circulating OLC. Our finding provides also indirect evidence 
for an endogenous nature of brain OLC. 
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